Moberg Derma: Strong Start for European Launch - All Milestones Expected in 2012
8/16/2012 9:48:50 AM
STOCKHOLM--(BUSINESS WIRE)--Moberg Derma (STO: MOB) expects to reach all remaining milestones in its agreement with Meda related to Nalox™ in 2012, generating a further MSEK 15.5. This assessment is based on a successful launch in several markets in Europe, including Germany and France. The launch of Nalox™ in Europe is progressing according to plan and it is expected that the remaining milestones in the agreement with Meda will be reached in 2012. To date, a total of MSEK 38.5 in milestone payments have been received, in addition to payments for delivered products, with a total of MSEK 15.5 in milestone payments remaining. In Italy, Menarini’s launch of the product also kicked off according to plan.